Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 10;13(2):41.
doi: 10.3390/jfb13020041.

GelMA Hydrogel Reinforced with 3D Printed PEGT/PBT Scaffolds for Supporting Epigenetically-Activated Human Bone Marrow Stromal Cells for Bone Repair

Affiliations

GelMA Hydrogel Reinforced with 3D Printed PEGT/PBT Scaffolds for Supporting Epigenetically-Activated Human Bone Marrow Stromal Cells for Bone Repair

Kenny Man et al. J Funct Biomater. .

Abstract

Epigenetic approaches using the histone deacetylase 2 and 3 inhibitor-MI192 have been reported to accelerate stem cells to form mineralised tissues. Gelatine methacryloyl (GelMA) hydrogels provide a favourable microenvironment to facilitate cell delivery and support tissue formation. However, their application for bone repair is limited due to their low mechanical strength. This study aimed to investigate a GelMA hydrogel reinforced with a 3D printed scaffold to support MI192-induced human bone marrow stromal cells (hBMSCs) for bone formation. Cell culture: The GelMA (5 wt%) hydrogel supported the proliferation of MI192-pre-treated hBMSCs. MI192-pre-treated hBMSCs within the GelMA in osteogenic culture significantly increased alkaline phosphatase activity (p ≤ 0.001) compared to control. Histology: The MI192-pre-treated group enhanced osteoblast-related extracellular matrix deposition and mineralisation (p ≤ 0.001) compared to control. Mechanical testing: GelMA hydrogels reinforced with 3D printed poly(ethylene glycol)-terephthalate/poly(butylene terephthalate) (PEGT/PBT) scaffolds exhibited a 1000-fold increase in the compressive modulus compared to the GelMA alone. MI192-pre-treated hBMSCs within the GelMA-PEGT/PBT constructs significantly enhanced extracellular matrix collagen production and mineralisation compared to control (p ≤ 0.001). These findings demonstrate that the GelMA-PEGT/PBT construct provides enhanced mechanical strength and facilitates the delivery of epigenetically-activated MSCs for bone augmentation strategies.

Keywords: 3D printing; GelMA; HDAC inhibitor; MI192; bone; epigenetics; hydrogel; tissue engineering.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1
Figure 1
The effects of MI192 on the proliferation and viability of hBMSCs within GelMA hydrogels. (a) DNA content of MI192-pre-treated/untreated hBMSCs within GelMA hydrogels during basal culture. (b) Merged live/dead staining of encapsulated hBMSCs within GelMA during osteogenic culture (live cells—green; dead cells—red). Scale bars = 50 µm. Data are presented as the mean ± SD (n = 3).
Figure 2
Figure 2
MI192 pre-treatment (48 h) enhances ALPSA in hBMSCs encapsulated in GelMA hydrogels compared with the untreated group after 2 weeks of osteogenic culture. Data are presented as the mean ± SD (n = 3). *** p ≤ 0.001.
Figure 3
Figure 3
Histological staining of MI192-pre-treated hBMSCs encapsulated within GelMA hydrogels after 6 weeks of osteogenic culture. (a) Picrosirius red staining for collagen production in the MI192-pre-treated constructs. (b) Quantitative analysis of picrosirius red collagen staining. (c) Alizarin red staining for calcium deposition with MI192-pre-treated hBMSCs. (d) Quantitative analysis of Alizarin red staining. (e) von Kossa staining for mineral nodules. (f) Semi-quantitative analysis of mineral nodules. Scale bars = 100 µm. Data are presented as the mean ± SD. *** p ≤ 0.001.
Figure 4
Figure 4
Effects of MI192 pre-treatment on Col1a and OCN expression in hBMSCs within GelMA hydrogels after 6 weeks of osteogenic culture. Scale bars = 200 and 50 µm for the low and high magnification, respectively.
Figure 5
Figure 5
Mechanical properties of GelMA, PEGT/PBT and the GelMA–PEGT/PBT construct. (a) Representative images of the GelMA–PEGT/PBT construct following photo-curing. (b) Compressive modulus of the GelMA hydrogel, the PEGT/PBT scaffold and the GelMA–PEGT/PBT construct. Data are presented as the mean ± SD. *** p ≤ 0.001.
Figure 6
Figure 6
Histological staining on the cross-sections of MI192 pre-treated/untreated hBMSCs encapsulated within GelMA–PEGT/PBT constructs after 6 weeks of osteogenic culture. (a) Picrosirius red staining for collagen production in the MI192-pre-treated GelMA–PEGT/PBT constructs. (b) Quantitative analysis of picrosirius red collagen staining. (c) Alizarin red staining for calcium deposition with the MI192-pre-treated GelMA–PEGT/PBT constructs. (d) Quantitative analysis of Alizarin red staining. (e) von Kossa staining for mineral nodules. (f) Semi-quantitative analysis of mineral nodules. Scale bars = 200 µm. Data are presented as the mean ± SD. ** p ≤ 0.01 and *** p ≤ 0.001. Note: the white elliptical spaces within the stained sections are the 3D printed PEGT/PBT fibres.

References

    1. Dimitriou R., Jones E., McGonagle D., Giannoudis P.V. Bone regeneration: Current concepts and future directions. BMC Med. 2011;9:66. doi: 10.1186/1741-7015-9-66. - DOI - PMC - PubMed
    1. Baroli B. From natural bone grafts to tissue engineering therapeutics: Brainstorming on pharmaceutical formulative requirements and challenges. J. Pharm. Sci. 2009;98:1317–1375. doi: 10.1002/jps.21528. - DOI - PubMed
    1. Calori G.M., Mazza E., Colombo M., Ripamonti C. The use of bone-graft substitutes in large bone defects: Any specific needs? Injury. 2011;42:S56–S63. doi: 10.1016/j.injury.2011.06.011. - DOI - PubMed
    1. Shegarfi H., Reikeras O. Review article: Bone transplantation and immune response. J. Orthop. Surg. (Hong Kong) 2009;17:206–211. doi: 10.1177/230949900901700218. - DOI - PubMed
    1. Amini A.R., Laurencin C.T., Nukavarapu S.P. Bone tissue engineering: Recent advances and challenges. Crit. Rev. Biomed. Eng. 2012;40:363–408. doi: 10.1615/CritRevBiomedEng.v40.i5.10. - DOI - PMC - PubMed